Louisiana

LOUISIANA MEDICARE SERVICES

“Noninvasive vascular studies utilize ultrasonic Doppler and physiologic principles to assess irregularities in blood flow in arterial and venous systems. The display may be a two dimensional image with spectral analysis and color flow or a plethysmographic recording.1 A hard copy, or a soft copy convertible to a hard copy, provides a permanent record of the study performed and must be of a quality that meets accepted standards2. Contrast arteriography and phlebography are standard diagnostic techniques for evaluation of arterial and venous diseases. These techniques are invasive and involve additional expense, time, discomfort and risks to the patient. Reliable, valid and accurate noninvasive studies are necessary to offset this problem. It is the responsibility of the provider to ensure the quality of the noninvasive studies. The accuracy of noninvasive vascular studies depends on the knowledge, skill and experience of the technologist and interpreter. Consequently, the providers of interpretations must be capable of demonstrating documented training and experience and maintain documentation for post-payment audit. All noninvasive vascular diagnostic studies must be either (1) performed by, or under the general supervision of, persons that have demonstrated minimum entry level competency by being credentialed in vascular technology, or (2) performed in laboratories accredited in vascular technology. Examples of appropriate personnel certification include the Registered Vascular Technologist (RVT) credential and the Registered Vascular Specialist (RVS) credential in Vascular Technology, and appropriate laboratory accreditation include the Intersocietal Commission for the Accreditation of Vascular Laboratories (ICAVL), or the American College of Radiology (ACR). Effective January 1, 2005, documentation of either the RVS, RVT or facility accreditation will be required each January prior to billing electronically for that new year and with any and all submitted paper claims. Supervisory levels of diagnostic tests must be in accordance with Program Memorandum B-01-28.”

close window